Revance Therapeutics Inc (RVNC):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Revance Therapeutics Inc (RVNC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7327
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fasciitis among others. It also provides RT001, a topical gel formulation of daxibotulinumtoxinA, which is designed to eliminate the use of needles. Revance Therapeutics develops products for multiple aesthetic and therapeutic applications. The company utilizes TransMTS platform technology for the development of its products. It offers products for dermatology, neurology, musculoskeletal disorders, urology and ophthalmology. Revance Therapeutics is headquartered in Newark, California, the US.

Revance Therapeutics Inc (RVNC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Revance Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Revance Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Equity Offering 13
Revance Therapeutics Plans to Raise upto USD125 Million in Public Offering of Shares 13
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 14
Revance Therapeutics Raises USD134.6 Public Offering of Shares 16
Revance Therapeutics Completes IPO For US$110.4 Million 18
Revance Therapeutics Inc – Key Competitors 20
Revance Therapeutics Inc – Key Employees 21
Revance Therapeutics Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 02, 2018: Revance releases second quarter 2018 results 23
May 08, 2018: Revance Releases First Quarter 2018 Results 24
Feb 28, 2018: Revance Announces Fourth Quarter and Full Year 2017 Financial Results 25
Aug 03, 2017: Revance Releases Second Quarter 2017 Results 26
May 09, 2017: Revance Releases First Quarter 2017 Results 27
Feb 27, 2017: Revance Releases Fourth Quarter and Full Year 2016 Results 28
Corporate Communications 30
Oct 11, 2018: Revance Therapeutics appoints Tobin C. Schilke as chief financial officer 30
Sep 20, 2018: Revance receives great place to work Certification 31
May 09, 2018: Revance Therapeutics Announces Two Recent Additions to Its Management Team 32
May 01, 2018: Revance Therapeutics Appoints Caryn McDowell As SVP, General Counsel & Corporate Secretary 33
Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors 34
Aug 02, 2017: Revance appoints new chief commercial officer and president of Aesthetics & Therapeutics 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Revance Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Revance Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Revance Therapeutics Plans to Raise upto USD125 Million in Public Offering of Shares 13
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 14
Revance Therapeutics Raises USD134.6 Public Offering of Shares 16
Revance Therapeutics Completes IPO For US$110.4 Million 18
Revance Therapeutics Inc, Key Competitors 20
Revance Therapeutics Inc, Key Employees 21
Revance Therapeutics Inc, Subsidiaries 22

List of Figures
Revance Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Revance Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Revance Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Revance Therapeutics Inc (RVNC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lundin Gold Inc:戦略・SWOT・企業財務分析
    Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BAE Systems Inc:企業の戦略・SWOT・財務情報
    BAE Systems Inc - Strategy, SWOT and Corporate Finance Report Summary BAE Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • India Glycols Ltd (INDIAGLYCO):企業の財務・戦略的SWOT分析
    India Glycols Ltd (INDIAGLYCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Vallourec SA:企業の戦略・SWOT・財務情報
    Vallourec SA - Strategy, SWOT and Corporate Finance Report Summary Vallourec SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • iTeos Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary iTeos Therapeutics SA (iTeos) is a biotechnology company that develops novel cancer immunotherapies. The company’s pipeline products include small molecule immunomodulators targeting IDO1, A2A, immune check points, STING agonist, and antibodies directed to TIGIT and Galectin 3. It also devel …
  • Time Technoplast Ltd.:戦略・SWOT・企業財務分析
    Time Technoplast Ltd. - Strategy, SWOT and Corporate Finance Report Summary Time Technoplast Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • EryDel SPA:製薬・医療:M&Aディール及び事業提携情報
    Summary EryDel SPA (EryDel), a subsidiary of Genextra Spa is a drug delivery company that develops drugs and diagnostics delivered through human red blood cells using a proprietary medical device technology. The company’s products include red cell loaders, and disposable kits for drug encapsulation …
  • Celixir Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Celixir Ltd (CTL), formerly Cell Therapy Ltd is a biotechnology company that discovers and develops regenerative medicines using adult stem cells for the treatment of heart failure. The company provids heartcel which is a type of stem cell therapy that provides improved outcomes for end-stag …
  • Metalfrio Solutions SA:企業の戦略・SWOT・財務情報
    Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report Summary Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TissueGen Inc:企業の製品パイプライン分析2018
    Summary TissueGen Inc (TissueGen) is a medical device company that develops fiber for advance drug delivery, nerve regeneration and tissue engineering. The company’s products comprise pharmaceutical fibers, growth factor fibers and stent. It offers pharmaceutical fibers and growth factor fibers. Tis …
  • Premier Farnell Ltd:企業の戦略的SWOT分析
    Premier Farnell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Fortum Corporation (FORTUM):電力:M&Aディール及び事業提携情報
    Summary Fortum Corporation (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power pl …
  • ConocoPhillips (COP):石油・ガス:M&Aディール及び事業提携情報
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • RCL Foods Ltd (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • MyCartis NV-医療機器分野:企業M&A・提携分析
    Summary MyCartis NV (MyCartis), formerly Pronota NV is a biomarker analysis solution provider. The company develops multiplexed biomarker solutions through evalution and bio assays technology. It uses technologies such as barcoded microparticles, microfluidic assay cartridges and evalution instrumen …
  • Agway Energy Services, LLC:企業の戦略的SWOT分析
    Agway Energy Services, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Bostwick Laboratories Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bostwick Laboratories Inc (Bostwick) is a medical laboratory that focuses on the interpretation of prostate and urological biopsies. The company offers services such as client services, clinical services, urologic laboratory services, and subspecialty laboratory services. Its urologic labora …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Tilaknagar Industries Ltd.:企業の戦略・SWOT・財務情報
    Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆